19. A customized targeted next-generation sequencing (NGS) panel for solid tumours: Analysis of the first 100 specimens

The aim of this study is to assess outcomes obtained on the first 105 samples using a customized solid tumour panel, covering hotspot regions in 31 genes. This 'Q31 assay' was recently implemented following a validation comprising of an amplicon-based QIAseq Targeted Panel, MiSeq, CLC Genomic Workbench for bioinformatics analysis and QCI-Interpret for variant interpretation and reporting.

Source: Cancer Genetics and Cytogenetics - May 31, 2020 Category: Genetics & Stem Cells Authors: Afia Hasnain, Shantanu Banerji, Ron Agatep, Tamara Dyck, Paul Park, Beth Spriggs Source Type: research